Unseen Kala-azar deaths in south Sudan (1999-2002). by Collin, Simon M et al.
Phuc, HK; Andreasen, MH; Burton, RS; Vass, C; Epton, MJ; Pape,
G; Fu, GL; Condon, KC; Scaife, S; Donnelly, CA; Coleman, PG;
White-Cooper, H; Alphey, L (2007) Late-acting dominant lethal ge-
netic systems and mosquito control. Bmc Biology, 5. ISSN 1741-7007
Downloaded from: http://researchonline.lshtm.ac.uk/9643/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution http://creativecommons.org/licenses/by/2.5/
BioMed Central
Page 1 of 11
(page number not for citation purposes)
BMC Biology
Open AccessResearch article
Late-acting dominant lethal genetic systems and mosquito control
Hoang Kim Phuc1, Morten H Andreasen1, Rosemary S Burton1, Céline Vass1, 
Matthew J Epton1, Gavin Pape1, Guoliang Fu2, Kirsty C Condon1,2, 
Sarah Scaife2, Christl A Donnelly3, Paul G Coleman3,4, Helen White-Cooper1 
and Luke Alphey*1,2
Address: 1Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK, 2Oxitec Limited, 71 Milton Park, Oxford OX14 
4RX, UK, 3Department of Infectious Disease Epidemiology, Imperial College Faculty of Medicine, Norfolk Place, London, W2 1PG, UK and 
4Department of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK
Email: Hoang Kim Phuc - hoangkim.phuc@zoo.ox.ac.uk; Morten H Andreasen - morten.andreasen@lshtm.ac.uk; 
Rosemary S Burton - rosemary.burton@zoo.ox.ac.uk; Céline Vass - celine@diversitas-international.org; 
Matthew J Epton - matthew.epton@zoo.ox.ac.uk; Gavin Pape - gpape@uk.ey.com; Guoliang Fu - guoliang.fu@oxitec.com; 
Kirsty C Condon - kirsty.condon@oxitec.com; Sarah Scaife - sarah.scaife@oxitec.com; Christl A Donnelly - c.donnelly@imperial.ac.uk; 
Paul G Coleman - paul.coleman@h2ovp.com; Helen White-Cooper - helen.white-cooper@zoo.ox.ac.uk; 
Luke Alphey* - luke.alphey@zoo.ox.ac.uk
* Corresponding author    
Abstract
Background: Reduction or elimination of vector populations will tend to reduce or eliminate
transmission of vector-borne diseases. One potential method for environmentally-friendly, species-specific
population control is the Sterile Insect Technique (SIT). SIT has not been widely used against insect disease
vectors such as mosquitoes, in part because of various practical difficulties in rearing, sterilization and
distribution. Additionally, vector populations with strong density-dependent effects will tend to be
resistant to SIT-based control as the population-reducing effect of induced sterility will tend to be offset
by reduced density-dependent mortality.
Results: We investigated by mathematical modeling the effect of manipulating the stage of development
at which death occurs (lethal phase) in an SIT program against a density-dependence-limited insect
population. We found late-acting lethality to be considerably more effective than early-acting lethality. No
such strains of a vector insect have been described, so as a proof-of-principle we constructed a strain of
the principal vector of the dengue and yellow fever viruses, Aedes (Stegomyia) aegypti, with the necessary
properties of dominant, repressible, highly penetrant, late-acting lethality.
Conclusion: Conventional SIT induces early-acting (embryonic) lethality, but genetic methods potentially
allow the lethal phase to be tailored to the program. For insects with strong density-dependence, we show
that lethality after the density-dependent phase would be a considerable improvement over conventional
methods. For density-dependent parameters estimated from field data for Aedes aegypti, the critical release
ratio for population elimination is modeled to be 27% to 540% greater for early-acting rather than late-
acting lethality. Our success in developing a mosquito strain with the key features that the modeling
indicated were desirable demonstrates the feasibility of this approach for improved SIT for disease control.
Published: 20 March 2007
BMC Biology 2007, 5:11 doi:10.1186/1741-7007-5-11
Received: 20 February 2007
Accepted: 20 March 2007
This article is available from: http://www.biomedcentral.com/1741-7007/5/11
© 2007 Phuc et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
BMC Biology 2007, 5:11 http://www.biomedcentral.com/1741-7007/5/11
Page 2 of 11
(page number not for citation purposes)
Background
Around the world, the medical and economic burden
caused by vector-borne diseases continues to grow as cur-
rent control measures fail to cope. There is an urgent need
to identify new control strategies that will remain effec-
tive, even in the face of growing insecticide and drug
resistance [1]. The Sterile Insect Technique (SIT) is a spe-
cies-specific and environmentally benign method for
insect population control that relies on the mass-rearing
and release of sterile insects [2-4]. These released insects
compete for mates with wild males; a wild female mating
with a released sterile male has no or fewer progeny, so the
population tends to decline. If sufficient sterile insects are
released for a sufficient period, the target population will
be controlled or even locally eradicated. SIT has been used
successfully for over 50 years for area-wide control and/or
elimination of several important agricultural pests and
disease vectors, including the Mediterranean fruit fly [5],
the screwworm fly [6,7] and the tsetse fly [8].
Though a number of trials were conducted in the 1970s,
with some success, there are today no large-scale SIT pro-
grams in operation against any mosquito species [9,10].
The mosquito Aedes aegypti (also known as Stegomyia
aegypti) is the key vector of the viruses that cause yellow
fever and dengue fever. Dengue fever has seen a four-fold
increase in incidence since 1970 and is a major public
health problem threatening an estimated 2.5 billion peo-
ple worldwide, with 50–100 million new infections per
year[11,12]. Ae. aegypti is a robust mosquito species, suit-
able for mass-rearing. This species also appears to be rea-
sonably homogeneous over large areas, without the
problems of cryptic sub-species and barriers to mating
and gene flow that have been found for some Anopheles
mosquitoes [13,14]. For mosquitoes, male-only release is
considered essential since sterile females will bite and so
may transmit disease, whereas male mosquitoes do not
bite. The early Aedes SIT trials showed that, even on a large
scale, sex-separation based on pupal size can consistently
give an essentially male-only population for release (< 1%
female; as low as 0.1% female if larger males are also dis-
carded [15]). A key difficulty for mosquito SIT is steriliza-
tion. Irradiation of pupae appears to damage the insects;
irradiation as adults is less damaging but operationally far
more difficult [16-19]. Some trials used sterilizing chemi-
cals such as thiotepa [20-22], which proved effective for
sterilization but led to trace contamination with this
mutagenic chemical [23].
Another problem for mosquito SIT relates to the popula-
tion biology of mosquitoes. Unlike agricultural pests,
against which the major SIT programs are currently
directed, mosquito populations may be regulated prima-
rily by density-dependent effects, in which a highly fecund
population is maintained at a stable level by resource lim-
itation, e.g. availability of oviposition sites or nutrients for
the larvae. Even a several-fold reduction in the average
reproductive potential of females might therefore have no
significant impact on the target population [24,25]. SIT
programmes have generally been directed against agricul-
tural pests which are not resource-limited, at least not lim-
ited by availability of larval food – which would imply
that they have eaten the entire crop. While this may apply
to a few agricultural pests under particular circumstances,
such as locusts or gypsy moths, agricultural pests are more
typically limited by seasonal effects and grower interven-
tions rather than intraspecific competition for resources
such as larval food.
We have previously proposed that insects engineered to
carry a dominant lethal genetic system could be used to
replace the need for radiation-sterilization in a SIT-like
control program [26,27]. We named this approach RIDL
(Release of Insects carrying a Dominant Lethal). Irradia-
tion acts by inducing random dominant lethals; in RIDL
this is replaced by an engineered dominant lethal. In both
RIDL and SIT, some or all of the progeny of released indi-
viduals die as a consequence of inheriting one or more
dominant lethal mutations, so the population tends to
decline. For population control purposes, the only timing
requirement for the lethal system is that death occurs
before reproductive maturity. However, it is clearly desir-
able that death occurs before the point at which the
insects cause harm. For mosquitoes, this is biting by adult
females or, for disease transmission, female biting after a
prior infected blood meal followed by pathogen incuba-
tion within the mosquito. Any lethal phase prior to adult-
hood is therefore acceptable. Radiation sterilization
generates random dominant lethal mutations in the
affected gametes, so the eggs laid by females inseminated
by sterile males die early in embryogenesis and do not
form larvae ("embryonic lethality"). This very early lethal
phase clearly satisfies the condition "before the point at
which the insect causes harm", but is not the only possi-
bility. We here propose an alternative strategy, the use of
a late-acting lethal, for example a pupal lethal, and show
that it can be significantly more effective than conven-
tional SIT at controlling populations limited by density-
dependent effects, e.g. limited availability of larval nutri-
tion.
Results and Discussion
Density-dependence
Density-dependent effects can stabilize a population at a
given level, the "carrying capacity", so that, if perturbed in
either direction, it will tend to return to that level. This is
a common situation for wild populations, for example
where individuals compete for limited resources such as
food. It has previously been reported that, in some such
cases, an SIT program with an insufficient release ratio
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could actually increase the stable adult population [24];
this prediction depends on assumptions that are not
unreasonable for some mosquito populations. Aedes
aegypti lays its eggs in small pools of relatively clean water,
e.g. rainwater, with relatively little organic matter and
therefore limited nutritional resources. Aedes pupae do
not feed; competition for resources is predominantly in
the larval phase. Sterilization with radiation or chemicals
would typically result in progeny that die early in embry-
onic development, and so would not compete with their
con-specifics for resources. This would lead to increased
survival of the remaining larvae, an effect that would
partly or completely offset the effect of killing some of the
embryos [24,25]. In contrast, in a RIDL program using a
strain with a late lethal phase, "doomed" heterozygotes
would compete for resources as larvae and so tend to
reduce the survival of their con-specifics. This could
potentially help to offset the "rebound" effect expected for
mosquito populations in the early stages of a conven-
tional SIT program, reducing the required release ratio,
and hence the cost and sustainability of the program. We
investigated this potentially beneficial effect by mathe-
matical modeling.
Modeling early-acting and late-acting lethality for Aedes 
aegypti
We compared the effectiveness of an early-acting lethal,
such as conventional SIT or an engineered lethal giving an
early lethal phase, with that of a RIDL system inducing
later-acting lethality. We used a mathematical model and
parameters for density-dependence derived from field
studies of Aedes aegypti [25]. We found that, for a popula-
tion limited by density-dependent effects, delaying the
time of death until after the density-dependent mortality
phase has a strongly beneficial effect on program effective-
ness (Fig. 1).
Under the assumptions of Fig. 1, use of a late-acting lethal
is shown to be the more effective for any level of control
effort, across the range of density-dependent and growth
rate parameters estimated for a natural Ae. aegypti popula-
tion [25]. Relative to an early-acting lethal, use of a late
lethal not only lowers the critical input ratio required to
achieve eradication (Fig. 1c–f), but also drives the popula-
tion more rapidly to the new control-mediated equilib-
rium (Fig. 1a, b). These benefits are more pronounced
where density-dependent effects are more pronounced,
under which circumstances the threshold release ratios for
population elimination are also higher (Fig. 1c). Impor-
tantly, use of a later lethal phase avoids any unintended
increase in the mosquito equilibrium population relative
to no control that may occur with an early-acting lethal
under intense density-dependence (Fig. 1c, e). Even if the
release rate is sufficient to avoid this over most of the pro-
gram area, for an early-acting lethal, there is a risk that
areas at or beyond the edge of the release area may incur
this problem. Avoiding such potentially deleterious con-
sequences of intervention, while reducing the effort and
time required to achieve successful population suppres-
sion, are important potential benefits of such a system.
The effectiveness of a RIDL strategy based on the use of a
late-acting lethal, relative to conventional SIT, is likely to
be even greater than Fig. 1 illustrates because our model
does not account for several advantages of RIDL, such as
reduced production costs and the competitiveness advan-
tage that transgenic males potentially have over irradiated
males. Use of a repressible lethal has the additional
advantage of a "fail-safe" protection against the conse-
quences of accidental release of mass-reared insects:
unlike conventional SIT, such insects require a dietary
additive for survival and therefore cannot establish in the
wild [28,29].
A mosquito strain with conditional late-acting dominant 
lethality
Can a mosquito strain with the necessary properties –
repressible dominant lethality acting at a larval or pupal
stage – actually be constructed? We transformed Ae.
aegypti with two molecular constructs, LA513 and LA882
(Fig. 2), predicted to induce tetracycline-repressible dom-
inant lethality in both males and females. We had previ-
ously found constructs of similar design to give late-
acting, primarily pupal, lethality in an agricultural pest
insect, the Mediterranean Fruit Fly Ceratitis capitata [28].
We recovered four transgenic lines, LA513A, LA513B,
LA882A and LA882B. All four appeared to be caused by
insertions at single sites in the genome, as judged by the
segregation pattern of the transgene over several genera-
tions of back-crossing to wild type (data not shown). Of
these four lines, three gave highly penetrant (95–100%)
tetracycline-repressible dominant lethality. Two of these,
LA513B and LA882A, killed affected individuals as early
larvae (L1–L3), which might give some degree of compe-
tition above that predicted for embryonic lethals, but is
not ideal for this purpose. The third line, LA513A, killed
affected individuals around the larval-pupal boundary, so
we investigated this line further. This variation in pheno-
type between insertion lines is known as "position effect"
and is a well-known consequence of the single-copy inte-
gration into random sites typical of insect transformation;
we have observed similar effects with equivalent con-
structs in other species ([28] and data not shown).
We found no difference in the survival of LA513A/+ trans-
genics and their wild type siblings when reared in the pres-
ence of 30 μg/ml tetracycline, but in the absence of
tetracycline only 3–4% of the transgenics survived from
the first larval instar to adulthood, compared with 86–
88% of wild type, a 95–97% reduction in survival relative
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Dynamics and equilibrium conditions of density-dependent-limited populations under RIDL/SIT controlFigure 1
Dynamics and equilibrium conditions of density-dependent-limited populations under RIDL/SIT control. We 
compared the effectiveness of SIT (blue line) and a late-acting lethal RIDL strategy (thick red line) in a mathematical model of a 
continuous breeding Ae. aegypti population limited by density-dependent mortality (for details of the model see Methods). The 
population is assumed to start at equilibrium carrying capacity, and will therefore remain at the initial level if there is no inter-
vention (black line). All releases are assumed to be of males only; the input release ratio, I, is defined relative to the initial wild 
male population; this rate of release of males then remains constant through time. In panels A and B, we plotted examples of 
the variation over time, from the start of control, of the number of females in the population relative to the initial number, for 
two different release ratios. The RIDL insects are assumed to be homozygous for a construct lethal to males and females 
("non-sex-specific") after the density-dependent phase. For conventional SIT, mortality is assumed to be early (at embryogene-
sis), before any density-dependent mortality operates. With a low release ratio (A), SIT can actually increase the equilibrium 
size of the adult female population while RIDL can result in eradication. With a sufficiently high release ratio (B), conventional 
SIT can control the population, but the RIDL strategy is more effective. In panels C, D, E and F, we plot the equilibrium number 
of female mosquitoes in the population, relative to the initial numbers, following control with a given input ratio. The critical 
input ratios required to achieve eradication are shown as broken lines for the conventional SIT (blue) and RIDL systems (red). 
β represents the intensity of the density-dependence; P is the maximum per capita daily egg production rate corrected for den-
sity-independent egg to adult survival (see Methods). Parameter values for β and P (indicated in the panels) represent the best-
estimate ranges calculated by Dye for a natural Ae. aegypti population [25]. In all cases, T = 27 days and δ = 0.12 per day; param-
eter values again taken from Dye [25].
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to wild type (Table 1). The LA513A line therefore has a
dominant lethal genetic system that is highly penetrant
and appears to be fully repressible.
We determined the lethal phase of LA513A in the absence
of tetracycline by crossing LA513A/+ heterozygotes to
wild type and monitoring the survival of progeny carrying
a single copy of the transgene (LA513A/+ heterozygotes),
relative to their non-transgenic siblings (Table 1). This
insertion was found by inverse PCR to be a precise integra-
tion at a TTAA target site (Suppl. Fig. 1B). The hatch rates
of transgenic and wild type larvae were not significantly
affected by the presence or absence of dietary tetracycline
(binomial exact test, p = 0.248). We found no difference
in survival to adulthood when the larvae were reared in
the presence of 30 μg/ml tetracycline (χ2 = 0.002, d.f. = 1,
p > 0.1). In the absence of tetracycline, highly significant
lethality was observed in transgenic individuals relative to
wild type (χ2 = 285, d.f. = 1, p < 0.001). Lethality of
LA513/+ was predominantly at the larval/pupal bound-
ary; most affected individuals that started to pupate failed
to develop beyond a very early pupal stage. The LA513A
line therefore carries a late-acting lethal, as desired and as
modeled in Figure 1.
Effect of incomplete penetrance of lethality
Our model assumed 100% penetrant lethality; LA513A
gave only 95–97%. We therefore extended the model to
explore the effect of incomplete penetrance. As shown in
Figure 3a–b, the effectiveness of a RIDL strategy using a
late-acting lethal is not particularly sensitive to incom-
plete penetrance of the lethal phenotype even under the
Dye's highest estimates of density dependent and growth
rate parameters conditions (i.e. β = 1 and P = 1.31) [25].
In particular, leakiness at the 3–5% level shown for
LA513A does not compromise the use or benefit of this
strategy, relative to a hypothetical, fully penetrant strain
(compare Fig 3a–b with Fig 1a–b; note change of axis
scale). This is consistent with a study by Barclay [30] on
the effect of incomplete sterility in a conventional SIT pro-
gram, in which he concluded that moderate levels of non-
sterility, e.g. 8%, would have little adverse effect, and that
incomplete sterility was likely to be less of a problem for
an SIT program directed against a population limited by
The structure and function of transposon LA513Figure 2
The structure and function of transposon LA513. LA513 is a non-autonomous piggyBac-based transposon of 8.4 kb. 
Transgenics are readily identified by red fluorescence due to expression of DsRed2. tTAV is a tetracycline-repressible tran-
scriptional activator [28, 48]. Here, tTAV is under the control of its own binding site, tetO, a minimal promoter from Dro-
sophila hsp70, and a 3' UTR sequence from Drosophila fs(1)K10 [49]. In the absence of tetracycline, tTAV binds to tetO and 
drives expression of more tTAV, in a positive feedback loop. In the presence of tetracycline, tTAV binds tetracycline; this tet-
racycline-bound form does not bind tetO and so does not lead to expression of more tTAV. Consequently, this construct 
gives very high levels of expression of tTAV in the absence of tetracycline, but only low, basal expression in the presence of 
tetracycline. High level expression of tTAV is toxic, possibly due to the interaction of the VP16 domain with key transcription 
factors, so this construct provides a tetracycline-repressible lethal system [28]. Construct LA882 is very similar to LA513; the 
principal difference is the use of the IE-2 promoter from the baculovirus OpNPV to drive expression of the DsRed2 marker, in 
place of Act5C.
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density-dependent effects than if the target population
were not so limited.
Effect of imperfect competitiveness of "doomed" larvae
Another assumption of our model is that the "doomed"
heterozygous larvae are fully competitive with wild type
larvae. Mosquito larvae do not directly fight each other for
food, rather they filter tiny particles of food from the sur-
rounding water, so this seems a reasonable assumption.
However, unless the transgene system is completely stage-
specific, transgenic individuals may be weakened by the
effect of the system before they are killed, and then might
not be fully competitive with wild type during the density-
dependent mortality phase. LA513A heterozygotes shows
some lethality at the L4 stage, which may indicate this,
though a study of density-dependent mortality in Aedes
aegypti [31] suggested that most such mortality is at earlier
larval stages. Any such lack of competitiveness would tend
to reduce the benefit of late-acting lethality. This effect is
explored in Fig. 3c–d. At the upper limit, C = 1, RIDL lar-
vae are fully competitive, and the outcome is therefore
identical to that of a late-acting lethal (red lines in Fig. 1a–
b). At the lower limit, C = 0, RIDL larvae are completely
uncompetitive, even if alive they contribute nothing to
density-dependent mortality and so have no effect on the
wild type larvae; the outcome is therefore identical to that
of early-acting lethality (blue lines in Fig. 1a–b). Fig. 3c–d
illustrates the effect of intermediate values of C. Most of
the benefit of late-acting lethality is obtained at values of
C = 0.7, in other words the effectiveness of the proposed
strategy is not particularly sensitive to imperfect larval
competitiveness.
Conclusion
We have investigated, by mathematical modeling, the
effect of adjusting the lethal phase in an SIT-like mosquito
control program. We found that, for a population limited
by density-dependent effects, delaying the time of death
until after the density-dependent mortality phase would
have a beneficial effect on program effectiveness, irrespec-
tive of assumptions about mass-release ratios or density-
dependence parameters, though the effect is stronger for
stronger density-dependence (Fig. 1). Our model does not
associate any differential performance penalty with use of
radiation or genetic engineering; the differential perform-
ance is solely due to adjusting the time of death. However,
eliminating radiation may provide additional improve-
ments. However, though radiation is generally highly
damaging for mosquitoes [18,32,33], there may be excep-
tions [19] and the magnitude of the fitness penalty associ-
ated with genetic engineering, if any [34,35], is also
somewhat controversial [34-38]. For density-dependent
parameters estimated from field data for Aedes aegypti, the
critical release ratio for population elimination is 27% to
540% greater for early-acting rather than late-acting
lethality (540%, 210%, 270% and 27%, respectively, for
the scenarios of Fig. 1c–f). This conclusion is also rela-
tively insensitive to incomplete larval competitiveness or
incomplete mortality, two likely imperfections in any
real-world implementation of our proposed strategy (Fig.
3).
LA513A has a highly penetrant, fully repressible, late-act-
ing, dominant lethal genetic system. This shows that it is
possible to construct such a strain of a major disease vec-
Table 1: Tetracycline-repressible lethality in LA513A. 
Cross Parents Progeny
Male Female Tc Genotype Egg L1 L2 L3 L4 Pupae Adults %
a LA513A/+ +/+ Yes LA513A/+ 1000 489 468 446 442 437 434 89
Wild type 444 431 403 400 396 392 88
b +/+ LA513A/+ Yes LA513A/+ 1000 442 420 404 399 393 383 87
Wild type 466 444 428 417 412 404 87
c LA513A/+ +/+ No LA513A/+ 540 274 265 235 208 155 7 2.6
Wild type 233 225 214 212 209 206 88
d +/+ LA513A/+ No LA513A/+ 497 216 205 181 168 131 9 4.2
Wild type 241 225 216 214 211 207 86
Adults heterozygous for LA513A were allowed to mate with wild type. a and c: transgenic males crossed to wild type females; b, d: the reciprocal 
cross using transgenic females. Eggs were collected and the resulting larvae reared in media supplemented with tetracycline (Tc) to 30 μg/ml 
(crosses a and b) or in normal, tetracycline-free media (crosses c and d). Data are the sum of at least 5 experiments. The ratio of transgenic to non-
transgenic first instar larvae (L1) was approximately 1:1 (1421:1384), indicating that there was no significant differential embryonic mortality 
between transgenic and wild type (binomial exact test,p = 0.248). The numbers of transgenic and non-transgenic first, second, third and fourth 
instar larvae (L1–L4), pupae and adults resulting from these eggs is shown. In the absence of tetracycline, the transgenics showed very high (96–
97%) mortality between first instar larvae and adult stages (highlighted cells); this was completely suppressed by tetracycline. Mortality of 
transgenics in the absence of tetracycline is strongly stage-specific, being primarily around the pupal stage (L4-pupae and pupae-adult; most affected 
individuals started to pupate but failed to develop beyond the earliest stages of pupal development).
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Sensitivity to incomplete lethality or competitivenessFigure 3
Sensitivity to incomplete lethality or competitiveness. We examined the impact of varying levels of lethality (pene-
trance) of the late-acting lethal (RIDL) system (a, b) or reduced competitiveness of the RIDL larvae (c, d) at release ratios of 2 
(panel a) or 7.5 (panel b) with β = 1 and P = 1.31, equivalent to Fig. 1a and b respectively. Apart from the new parameters L and 
C (below), all other parameter values and assumptions about density-dependent mortality, relative mating competitiveness and 
release ratios are as for Fig. 1. (a, b) In each case, the lethality, L, associated with inheritance of a single copy of the RIDL con-
struct was examined at values of L = 1, 0.95, 0.9, 0.8, 0.7 and 0.5. At L = 1, the outcome is identical to that of shown in Fig. 1 
(red lines in Fig 1a, b). (c, d) The contribution of larvae carrying RIDL constructs to the overall density-dependent mortality 
experienced by all larvae in the generation was examined by varying a competitiveness scaling factor, C, between 1 (i.e. RIDL 
larvae are as competitive as the wild type and contribute equally to density-dependent mortality) and 0 (i.e. RIDL larvae con-
tribute nothing to density-dependent mortality – this scenario is equivalent to an early acting conventional SIT system). C = 1 
and C = 0 therefore correspond to the red and blue lines, respectively, in Fig. 1a,b.
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tor, using current technology, and thereby makes the
modeling and theoretical discussion relevant to real con-
trol programs and strategies. LA513B and LA882B, and
most insertion lines of equivalent constructs in Medfly
(Ceratitis capitata) and Drosophila melanogaster [[28] and
data not shown] also show highly penetrant, fully repress-
ible, dominant lethality. This indicates that this is a repro-
ducible property of these constructs, and not particularly
dependent on the precise insertion site (but not a univer-
sal property – LA882A showed no significant lethality
even in the absence of tetracycline [data not shown]).
However, time of death appears to be more sensitive to
position effect in both Aedes aegypti and Ceratitis capitata,
so a large panel of insertion lines might be required to
find one that combines late-acting lethality with the other
necessary characteristics for field use such as good flight
ability, mating competitiveness, longevity in the field, etc.
LA513A demonstrates the principle that transgenic strains
may be constructed with repressible, dominant, late-act-
ing lethality, but not that this is the only or optimal
molecular strategy for achieving this phenotype. Rather
than the "positive feedback" system of LA513, use of a
late-acting promoter in a more conventional bipartite
expression system might perhaps give more reliable con-
trol over the time of expression of an effector molecule
and hence the lethal phase; this has previously been dem-
onstrated in Drosophila for female-specific promoters and
for embryo-specific promoters [27,39,40].
The recent development of genetic transformation meth-
ods for mosquito species has opened the door to a range
of approaches to the control of disease transmission that
are based on manipulating the genome of the mosquito
vector [41]. Population replacement strategies, which aim
to convert a pathogen-transmitting mosquito population
into one incapable of transmission, may provide the best
solution in the long term, particularly for poorer regions
with very large mosquito populations. However, genetics-
based population suppression and elimination strategies,
such as RIDL and conventional SIT, have considerable
potential applicability in many parts of the world. Since it
requires rather simpler molecular biology and genetics,
RIDL may be available much earlier than systems based
on population replacement. From a regulatory point of
view RIDL is also somewhat less challenging, as an auto-
cidal system will rapidly eliminate itself from the environ-
ment unless deliberately maintained by constant re-
introduction. It has therefore been suggested that SIT
should be the first application for field release of trans-
genic insects [10]. We have shown here that a mosquito
strain with the genetic properties (late-acting, repressible
dominant lethality) necessary for the RIDL strategy we
propose can indeed be constructed, and that, for mosqui-
toes, this system has significant theoretical advantages
over classical SIT. However, political action has derailed at
least one mosquito SIT program in the past [42,43], and it
will be essential to obtain broad political support and reg-
ulatory approval if this method is indeed to help to reduce
the burden of vector-borne disease.
Materials and methods
Mathematical model of mosquito population dynamics
The dynamics of the wild type adult mosquito popula-
tion, A, through time, t, are described by a time-delayed
differential equation model (which captures the overlap-
ping generations characteristic of Ae. aegypti), with a two-
parameter, α and β, density-dependent function [25]. The
model, which assumes density-dependent mortality acts
on pre-adultlife stages, takes the form
in which T is the mosquito generation time, δ is the per
capita daily adult death rate, E is the maximum per capita
daily egg production rate, and P is the maximum per cap-
ita daily egg production rate corrected for density-inde-
pendent egg to adult survival. We assume a 1:1 sex ratio.
In the absence of any control, the maximum finite rate of
increase (net fecundity after lifetime density-independent
mortalities), λ, is
and the equilibrium adult population size, A*, is
In evaluating the performance of the conventional SIT
(early-acting lethality) and RIDL (late-acting lethality)
systems we assume the population is at pre-control stable
equilibrium when SIT control is initiated (i.e. A0 = A*. The
input ratio, I, of released males is defined relative to the
pre-control population equilibrium, A*, such that the
number of "sterile" males remains constant through time.
Under both release scenarios, females are assumed to
select mates proportionately to their relative abundance.
Therefore, for the constant number release scenario the
proportion of females that mate with wild type males at
time t is At/(At + IA*).
With the early-acting lethal, we assume that the all off-
spring of sterile males die at early embryogenesis and so
do not contribute to density-dependent mortality in pre-
d
d
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adult life stages. The dynamics of the mosquito popula-
tion under conventional SIT control is given by
In contrast, for late acting lethality, we assume all off-
spring of "sterile" males survive through the pre-adult life
stages and contribute fully to density-dependent mortal-
ity, before dying prior to adult emergence. The resulting
population dynamics under RIDL control are described by
For any value of I > 0, the population will move away
from A* towards a new, control-mediated equilibrium. If
the release ratio exceeds a critical threshold, I*, the wild
type population will be driven to extinction (i.e. control-
mediated equilibrium = 0).
The relative performance of the conventional SIT and
RIDL systems was examined by simulating equations 4
and 5 over a range of values of I and for different combi-
nations of parameters values for β (0.302 and 1) and P
(0.367 and 1.31), representing the range estimated by Dye
[25]. For each combination of β and P, the critical release
ratio for population eradication was estimated numeri-
cally for both early and late lethality approaches. The sim-
ulation was conducted using a one-day time step; at each
time step the magnitude of At was divided by A* so as to
scale the wild type adult population relative to the pre-
control equilibrium. This relative measure of adult popu-
lation numbers is independent of the magnitude of α and
E (for all non-zero values of α and E) and is equivalent to
the relative adult female mosquito population (as the egg
sex ratio is equal). A simulation approach was adopted
because there are no analytical solutions for the critical
release ratios, nor the equilibrium population sizes for
values of I > 0.
To model the effect of incomplete penetrance of RIDL-
induced mortality, the equation describing the dynamics
of mosquito population under RIDL control (equation 5)
was adjusted to account for the proportion of lethality, L,
giving
To model the effect of reduced competitiveness of RIDL
larvae, relative to wild type, equation 5 was adjusted to
incorporate a competitiveness scaling factor, C, which can
take values between 1 (RIDL larvae are fully competitive
and contribute equally to density-dependent mortality)
and 0 (RIDL larvae contribute nothing to density-depend-
ent mortality giving
C can take values between 1 (RIDL larvae are fully com-
petitive and contribute equally to density-dependent mor-
tality) and 0 (RIDL larvae contribute nothing to density-
dependent mortality).
Mosquito transformation and rearing
Aedes aegypti of the Rockefeller strain (obtained from
Roger Wood, University of Manchester), were reared in an
insectary maintained at 28°C and 75–80% relative
humidity with 12-hour light/dark cycle. Mosquitoes were
transformed by standard micro-injection methods [44],
using a vector plasmid (e.g. pLA513) concentration of 500
ng/μl coinjected with a 400 ng/μl concentration of piggy-
Bac 'helper plasmid' phsp-pBac [45] as the source of piggy-
Bac transposase. After injection, eggs were heat shocked at
37°C for 2 hours, then stored for 48 hours at 100%
humidity before they were submerged for hatching. Adult
injection survivors ('Generation 0' or G0) were back-
crossed to wild type: individual G0 males were crossed to
10–15 wild type females and G0 females were combined
in pools of 10 with 3 wild type males. G1 eggs were col-
lected and hatched as above (but without heat-shock).
Hatched G1 larvae were screened for fluorescence using an
Olympus SZX-12 microscope equipped for fluorescence
(filters for red fluorescence: excitation 510–550, emission
590LP). Two independent transgenic lines, designated
LA513A and LA513B, were recovered from about 200 fer-
tile G0 back crosses, representing a transformation effi-
ciency of approximately 1%. This is lower than published
piggyBac-mediated transformation rates for Aedes aegypti
of 8–11% [46,47]. This decrease may reflect the larger size
of the LA513 construct, some loss of some transgenics due
to the deleterious effect of overexpression of tTAV, and/or
variations in experimental technique or environment.
DsRed2 fluorescence could be observed in the thorax of
all developmental stages of LA513A mosquitoes. For the
experiments in Table 1, larvae were reared at 200–250 lar-
vae per liter, with 5–8 pellets of fish food (Omega) every
2 days. Tetracycline (Sigma) was added to the larval water
to a final concentration of 30 μg/ml, as appropriate. Eggs
were washed carefully after collection to minimize carry-
over of tetracycline from one generation to the next. Males
and females were separated as pupae to ensure female vir-
ginity for all experimental crosses.
Molecular analysis
Inverse PCR to identify genomic sequence adjacent to the
insertion site of LA513A was performed as Handler et al.
[45], using HaeIII, MspI and TaqI restriction enzymes.
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Inverse PCR products were cloned into pCRII-TOPO (Inv-
itrogen, Paisley, UK) prior to sequencing.
List of abbreviations used
SIT: Sterile Insect Technique
RIDL: Release of Insects carrying a Dominant Lethal
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